Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rizobacter Argentina S.A. Interim / Quarterly Report 2021

Feb 17, 2021

68520_rns_2021-02-17_8f237efd-a694-4425-a23d-a74bb5eb19dc.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

(Registration Number 2015 / 308733 / 07) Management Statements for the 6 month period ended 31 December 2020

Compiled Financial Statements

in compliance with Companies Act 71 of 2008 Compiled by: Chanette Haasbroek CA(SA)

(Registration Number 2015 / 308733 / 07) Management Statements for the 6 month period ended 31 December 2020

Index

The reports and statements set out below comprise the financial statements presented to the shareholders:

General Information 1
Report of the Compiler 2
Statement of Financial Position 3
Statement of Comprehensive Income 4
Statement of Changes in Equity 5
Statement of Cash Flows 6
Supplementary information:
Detailed Income Statement
7

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2020

General Information

Country of Incorporation and Domicile South Africa
Nature of Business and Principal Activities Agriculture
Directors AG Lehmann
PE Mac Mullen
Registered Office
Business Address
510 Makou Street
Monument Park x 2
Pretoria
Gauteng
0181
510 Makou Street
Monument Park x 2
Pretoria
Gauteng
0181
Bankers The Standard Bank of South Africa Limited
Compiler Chanette Haasbroek CA(SA)
494 Road A
Rietvalleirand x 32
Pretoria
Gauteng
0042

fi[ISE fUrUfiEr{l\$E

Report of the Compiler

To the Directors of Rizobacter south Africa {fty) [td

I have compiled the accompanying management statemenG of Rizobacter South Africa (Pty) Ltd based on information you have provided. These management statements comprise the statement of financial position of Rizobacter South Africa (Pty) Ltd ai at 31 December 2020, the statement of comprehensive income, the statement of changes in equity and the statement of cash flows for the 6 month period then ended, a summary of significant a6counting policies and oth€r explanatory information.

I performed this compilation engagement in accordance with lnternational Standard on Related services 4410 (Revised), Compilation Engagements.

I have applied my expertise in accounting and financial reporting to assist you in the preparation and presentation of these management statements in accordance with the lnternational Financial Reporting Standard for Small and Medium-sized Entities and the requirements oJ the Companies Act of South Africa. I have complied with reievant ethical requirements, including principles of integrity, objectivity, professional competence and due care.

These management statements and the accuracy and completeness of the information used to compile them are your responsibility.

Since a compilation engagement is not an assurance engagement, I am not required to verify the a€curacy or completeness of the information you provided to me to compile these management statements. Accordingly, I do not express an audit opinion or a review conclusion on whether these management statements are prepared in accordance with the lnternational Financial Reporting Standard for Small and Medium-sized Entities and the requirements of the Companies Act of South Africa.

Director / Partner chartered Accountant {5A)

6 January 2021

494 Road A Rietvalleirend x 32 Pr€toria Gauteng 0042

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2020

Statement of Financial Position

Figures in R Notes 31 December 202030 June 2020
Assets
Non-Current Assets
Property, plant and equipment 3 7,671 10,402
Loan to shareholder 8,334 8,334
16,005 18,736
Current Assets
Trade and other receivables 4 1,062,448 105,990
Cash and cash equivalents 5 40,202 212,689
1,102,650 318,679
Total Assets 1,118,655 337,415
Equity and Liabilities
Equity
Issued capital 6 686,683 686,683
Accumulated loss (70,002) (372,309)
616,681 314,374
Current Liabilities
Trade and other payables 8 501,974 23,041
Total Equity and Liabilities 1,118,655 337,415

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2020

Statement of Comprehensive Income 6 months
Figures in R Notes 31 December 202030 June 2020
Revenue 1,212,331 482,917
Cost of sales (512,355) -
Gross profit 699,976 482,917
Other income 9 - 1,075
Operating costs (397,669) (843,481)
Operating profit / (loss) 302,307 (359,489)
Finance costs 11 - (7,059)
Profit / (loss) for the year 302,307 (366,548)

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2020

Statement of Changes in Equity

Accumulated
Figures in R Share capital loss Total
Balance at 1 July 2019 120,000 (5,761) 114,239
Total comprehensive income for the
year
Loss for the year (366,548) (366,548)
Total comprehensive income for the
year - (366,548) (366,548)
Issue of share capital 566,683 566,683
Balance at 30 June 2020 686,683 (372,309) 314,374
Balance at 1 July 2020 686,683 (372,309) 314,374
Total comprehensive income for the
year
Profit for the year 302,307 302,307
Total comprehensive income for the
year - 302,307 302,307
Balance at 31 December 2020 686,683 (70,002) 616,681
Note 6

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2020

Statement of Cash Flows 6 months
Figures in R Note(s) 31 December 202030 June 2020
Cash flows used in operating activities
Profit/(loss) for the year 302,307 (366,548)
Adjustments for:
Finance costs - 7,059
Depreciation of property, plant and equipment 2,731 89,437
Operating cash flow before working capital changes 305,038 (270,052)
Working capital changes
(Increase)/decrease in trade and other receivables (956,458) 442,715
Increase in short term loans - (511,547)
Increase/(decrease) in trade and other payables 478,933 (16,673)
Net cash flows used in operations (172,487) (355,557)
Finance costs - (7,059)
Net cash flows used in operating activities (172,487) (362,616)
Cash flows from financing activities
Capital issued - 566,683
Shareholder's loan repaid - (28,334)
Net cash flows from financing activities - 538,349
Net (decrease) / increase in cash and cash equivalents (172,487) 175,733
Cash and cash equivalents at beginning of the year 212,689 36,956
Cash and cash equivalents at end of the year 5 40,202 212,689

(Registration Number 2015 / 308733 / 07)

Management Statements for the 6 month period ended 31 December 2020

Detailed Income Statement 6 months
Figures in R 31 December 202030 June 2020
Gross Revenue
Commission received 765,068 482,917
Consulting fee income 447,263 -
1,212,331 482,917
Cost of Sales
Purchases 512,355 -
512,355 -
Gross Profit 699,976 482,917
Other Income
Profit on foreign exchange - 1,075
- 1,075
699,976 483,992
Expenditure
Accounting fees 29,300 57,975
Bank charges 1,077 3,332
Compiler's remuneration 9,000 8,500
Computer expenses 3,522 3,268
Consulting fees 263,319 52,474
Depreciation - Tangible assets 2,731 89,437
Electricity and water 7,068 17,015
Field and Greenhouse trials 2,790 393,534
Finance costs - 7,059
Insurance 9,352 28,050
Lease rental on operating lease 53,216 106,485
Legal expense - 1,891
Logistics: Samples and others (683) 56,697
Loss on foreign exchange 8,005 -
Marketing - 4,348
Motor vehicle expense
SABO Membership fees
1,215
-
2,011
5,000
Secretarial fees 150 100
Telephone and internet 7,607 13,364
397,669 850,540
Profit / (loss) for the year 302,307 (366,548)